JP Morgan Private Wealth Advisors’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,667
Closed -$77K 2089
2021
Q4
$77K Hold
1,667
﹤0.01% 1949
2021
Q3
$112K Sell
1,667
-682
-29% -$56K ﹤0.01% 1896
2021
Q2
$251K Hold
2,349
﹤0.01% 1740
2021
Q1
$358K Hold
2,349
﹤0.01% 1459
2020
Q4
$393K Hold
2,349
﹤0.01% 1383
2020
Q3
$367K Hold
2,349
﹤0.01% 1280
2020
Q2
$492K Buy
+2,349
New +$484K ﹤0.01% 1103

Other funds holding TECX

JP Morgan Private Wealth Advisors's TECX Position: Q1 2022 in Review

JP Morgan Private Wealth Advisors sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 1,667 shares — an estimated $77K sold.

JP Morgan Private Wealth Advisors first reported a position in TECX in Q2 2020 and held it in 7 quarters. The position peaked at $492K in Q2 2020. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 1,667 Tectonic Therapeutic shares in Q1 2022, an estimated $77K.
  • JP Morgan Private Wealth Advisors first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 7 quarters.
  • JP Morgan Private Wealth Advisors's Tectonic Therapeutic position peaked at $492K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.